Future perspectives for personalized immunotherapy in renal cell carcinoma

Expert Opin Biol Ther. 2017 Sep;17(9):1049-1052. doi: 10.1080/14712598.2017.1339030. Epub 2017 Jun 7.

Authors

Chiara Ciccarese¹, Vincenzo Di Nunno², Roberto Iacovelli¹, Francesco Massari²

Affiliations

¹ a Medical Oncology , University Hospital of Verona , Verona , Italy.
² b Division of Oncology , S.Orsola-Malpighi Hospital , Bologna , Italy.

PMID: 28592155
DOI: 10.1080/14712598.2017.1339030

No abstract available

Keywords: CTLA-4; Immunotherapy; PD-L1; PD1; TKI; VEGF; personalized therapy; renal cell carcinoma.

Publication types

Editorial